The identification of medicinal products (IDMP) standards will help make sure patients get the right medicines and make it easier to detect problems when things go wrong.

A regulator responds to the public outcry against patient harms suffered by women with surgical mesh implants.

Recent investigations into faulty medical device regulation have highlighted the need to broaden the scope of pharmacovigilance, to include more than just medications.

Pharmacovigilance has officially become one of the main initiatives of the CSDR with the creation of a dedicated committee, who held their first plenary meeting in April this year.

Following serious complications experienced by women with surgical mesh implants, patients and authorities alike believe tighter regulation on medical devices is needed.

Since implementing this module into its safety reporting process, INVIMA has seen marked improvements in the quality, quantity, and timeliness of reports sent to VigiBase.

New 10-point plan urged to improve detection, analysis, and reporting of harms from medicines and devices to improve patient safety.

There was no chance the new head of the European Union’s medicines regulator could simply ease into the job. Emer Cooke, had Brexit and a pandemic on her desk from day one.